Forma

Forma Therapeutics to Report Second Quarter 2022 Financial Results and Provide Business Update on August 5, 2022

Retrieved on: 
Friday, July 29, 2022
Biotechnology, Pharmaceutical, Health, Clinical Trials, RBC, Thalassemia, PIN, Sickle cell disease, Research, Prostate cancer, Health, Therapy, PKR, EDT, Cancer, Patient, LinkedIn, Nasdaq, Forma, SCD, MDS, Degenerative disease, Pharmaceutical industry

Forma Therapeutics Holdings, Inc. (Nasdaq: FMTX), a clinical-stage biopharmaceutical company focused on sickle cell disease (SCD), prostate cancer and other rare hematologic diseases and cancers, today announced that it will release second quarter 2022 financial results Friday, August 5, 2022.

Key Points: 
  • Forma Therapeutics Holdings, Inc. (Nasdaq: FMTX), a clinical-stage biopharmaceutical company focused on sickle cell disease (SCD), prostate cancer and other rare hematologic diseases and cancers, today announced that it will release second quarter 2022 financial results Friday, August 5, 2022.
  • Forma management will host an investment community conference call at 8 a.m. Eastern Daylight Time (EDT) on August 5, 2022 to discuss these financial results and provide a business update.
  • A live webcast of the conference call will be available in the News & Investors section of Formas website at www.formatherapeutics.com .
  • Forma Therapeutics is a clinical-stage biopharmaceutical company focused on the research, development and commercialization of novel therapeutics to transform the lives of patients with rare hematologic diseases and cancers.

Forma Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

Retrieved on: 
Tuesday, July 12, 2022
Oncology, Health, Other Health, General Health, Pharmaceutical, Biotechnology, Forma, Board of directors, Development, Senior, Incentive stock option, Therapy, LinkedIn, Employment, Patient, Degenerative disease, Cancer, Nasdaq, Research and development, Sickle cell disease, RSU, Inducement rule, Board, Prostate cancer, Finance Secretary (India), NASDAQ, Pharmaceutical industry, Research

The Inducement Grants were granted on July 11, 2022.

Key Points: 
  • The Inducement Grants were granted on July 11, 2022.
  • The Inducement Grants were issued outside of Forma Therapeutics stockholder-approved equity incentive plan, pursuant to Rule 5635(c)(4) of the NASDAQ Listing Rules as an inducement material to Dr. Melin and Ms. Aspesi entering into employment with Forma.
  • The Inducement Grants are subject to the terms and conditions of the forms of award agreement covering each grant.
  • Forma Therapeutics is a clinical-stage biopharmaceutical company focused on the research, development and commercialization of novel therapeutics to transform the lives of patients with rare hematologic diseases and cancers.

Forma Announces New Specialty Health Reimbursement Arrangement

Retrieved on: 
Monday, July 11, 2022
Emerging Capital Partners, Health, Solution, COVID-19, Stripe, CEO, HRIS, Program, Transport, Specialty, AngelPad, Twic State, Government, Supreme court, SFTP, Compliance, HIPAA, HRA, Lululemon Athletica, Wildfire, GLOBE, Law of the United Kingdom, SAN, Meal, Dropbox, Health insurance, Forma, Block

SAN FRANCISCO, July 11, 2022 (GLOBE NEWSWIRE) -- Forma , the life benefits platform, today announced that it will offer a Specialty Health Reimbursement Arrangement (HRA) solution in addition to its current benefits offerings.

Key Points: 
  • SAN FRANCISCO, July 11, 2022 (GLOBE NEWSWIRE) -- Forma , the life benefits platform, today announced that it will offer a Specialty Health Reimbursement Arrangement (HRA) solution in addition to its current benefits offerings.
  • The newly launched Specialty HRA is a defined contribution, account-based plan aimed to cover the cost of specific abortion and abortion medical travel-related health expenses not adequately covered by group medical plans.
  • In response to the Supreme Court decision to overturn Roe vs. Wade, many companies are looking for solutions that support employees' reproductive health care.
  • Reproductive care is deeply personal and is a part of core healthcare, said Jason Fan, CEO and co-founder at Forma.

Forma Therapeutics Announces Appointment of New Executive Team Members

Retrieved on: 
Thursday, June 30, 2022
Oncology, Health, Other Health, General Health, Clinical Trials, Pharmaceutical, Biotechnology, Patient, LinkedIn, CEO, Head, Research, Office management, Degenerative disease, Sickle cell disease, Lineae, Trial of the century, COVID-19, Yale University, Biophysics, Industry, Goal, Annual report, National Association Medical Staff Services, Employment, Alexion Pharmaceuticals, Form 10-Q, Development, U.S. Securities and Exchange Commission, Merck, Cancer, Therapy, SVP, Private Securities Litigation Reform Act, EVP, Nasdaq, Culture, SEC, Risk, Prostate cancer, Safety, Pharmaceutical industry, Medicine, Swedish Orphan Biovitrum, Brigham, Sanofi, Forma

Forma Therapeutics Holdings, Inc. (Nasdaq: FMTX), a clinical-stage biopharmaceutical company focused on sickle cell disease, prostate cancer, and other rare hematologic diseases and cancers, today announced the appointment of Agustn Melin, M.D.

Key Points: 
  • Forma Therapeutics Holdings, Inc. (Nasdaq: FMTX), a clinical-stage biopharmaceutical company focused on sickle cell disease, prostate cancer, and other rare hematologic diseases and cancers, today announced the appointment of Agustn Melin, M.D.
  • In this capacity, he led the cross-functional research and development medical staff outside of the U.S. as well as Japan.
  • Forma has a differentiated patient-centric culture and an amazing team.
  • Forma Therapeutics is a clinical-stage biopharmaceutical company focused on the research, development, and commercialization of novel therapeutics to transform the lives of patients with rare hematologic diseases and cancers.

Forma Announces New Partnership with DriveWealth to Launch Industry-First Health Savings Account

Retrieved on: 
Wednesday, June 29, 2022
Emerging Capital Partners, Acquisition, LinkedIn, CEO, Adoption, COVID, GLOBE, API, Lululemon Athletica, Industry, Health, Twic State, HSAS, ETF, SAN, Partnership, Traction, CAGR, Dropbox, Stripe, AngelPad, HSA, UBS, Twitter, Bank, Life insurance, Block, Forma

SAN FRANCISCO, June 29, 2022 (GLOBE NEWSWIRE) -- Forma , the life benefits platform, today announced the company is partnering with DriveWealth to launch Forma HSA, a health savings account solution that offers the industrys first savings account with no minimum balance requirement for investment and no hidden fees.

Key Points: 
  • SAN FRANCISCO, June 29, 2022 (GLOBE NEWSWIRE) -- Forma , the life benefits platform, today announced the company is partnering with DriveWealth to launch Forma HSA, a health savings account solution that offers the industrys first savings account with no minimum balance requirement for investment and no hidden fees.
  • Forma is addressing the market demand by providing a comprehensive HSA solution that gives consumers more power to invest and reap the benefits of health savings accounts.
  • In partnership with DriveWealth, we are bringing to market a first-of-its-kind HSA offering to empower employees to gain value from tax-advantaged health saving accounts.
  • With Forma HSA, employees can invest in their long-term health as soon as they open an account without needing a minimum balance.

Workday Elects Wayne A.I. Frederick, M.D. to Board of Directors

Retrieved on: 
Wednesday, June 22, 2022
New York state public-benefit corporations, Carnegie Corporation of New York, Democracy, WDAY, Howard University, Knowledge, Fellowship of the Royal Colleges of Surgeons, American College, American Surgical Association, Roswell Park Comprehensive Cancer Center, University, NASDAQ, Mutual, Humana, Forma, Mutual of America, Management

PLEASANTON, Calif., June 22, 2022 /PRNewswire/ -- Workday, Inc. (NASDAQ:WDAY), a leader in enterprise cloud applications for finance and human resources, today announced that its board of directors has elected Wayne A.I. Frederick, M.D. as an independent director.

Key Points: 
  • PLEASANTON, Calif., June 22, 2022 /PRNewswire/ -- Workday, Inc. (NASDAQ:WDAY), a leader in enterprise cloud applications for finance and human resources , today announced that its board of directors has elected Wayne A.I.
  • He is currently the president of his alma mater, Howard University, having held this position since July 2014.
  • Prior to this appointment, he was the institution's interim president after serving as its provost and chief academic officer.
  • He is a fellow of the American College of Surgeons and is a member of the American Surgical Association.

Forma Therapeutics to Present at the Jefferies Healthcare Conference

Retrieved on: 
Friday, June 3, 2022
Oncology, Health, General Health, Research, Science, Pharmaceutical, Biotechnology, LinkedIn, Therapy, Patient, Forma, EDT, Degenerative disease, Cancer, Sickle cell disease, Conference, Research, Nasdaq, Prostate cancer, Pharmaceutical industry

Forma Therapeutics Holdings, Inc. (Nasdaq: FMTX), a clinical-stage biopharmaceutical company focused on sickle cell disease, prostate cancer and other rare hematologic diseases and cancers, today announced that it will participate in the Jefferies Healthcare Conference taking place June 8-10, 2022.

Key Points: 
  • Forma Therapeutics Holdings, Inc. (Nasdaq: FMTX), a clinical-stage biopharmaceutical company focused on sickle cell disease, prostate cancer and other rare hematologic diseases and cancers, today announced that it will participate in the Jefferies Healthcare Conference taking place June 8-10, 2022.
  • Forma will present on June 9, 2022 at 2:00 p.m. Eastern Daylight Time (EDT).
  • Forma Therapeutics is a clinical-stage biopharmaceutical company focused on the research, development and commercialization of novel therapeutics to transform the lives of patients with rare hematologic diseases and cancers.
  • Our work has generated a broad proprietary portfolio of programs with the potential to provide profound patient benefit.

Forma to Sponsor SHRM22 Annual Conference June 12-15

Retrieved on: 
Tuesday, May 31, 2022
HR, AngelPad, Health, Stripe, Workplace, Zoom, Privacy, HRIS, Twic State, Workforce, SAN, Lululemon Athletica, Conference, Program, Acquisition, Emerging Capital Partners, GLOBE, Nightclub, Square, Forma

SAN FRANCISCO, May 31, 2022 (GLOBE NEWSWIRE) -- Forma, the life benefits platform, today announced the company will be a participating sponsor for the SHRM22 Annual Conference , the worlds largest convening event of HR professionals.

Key Points: 
  • SAN FRANCISCO, May 31, 2022 (GLOBE NEWSWIRE) -- Forma, the life benefits platform, today announced the company will be a participating sponsor for the SHRM22 Annual Conference , the worlds largest convening event of HR professionals.
  • Forma will sponsor the event as an exhibitor with a booth located at 2160 in the exhibit hall, where the team will discuss the power of flexible benefits programs with conference participants.
  • The team will also host a raffle for booth visitors and anyone that engages with the Forma team during the conference.
  • What: Forma will be a sponsor at the SHRM22 Annual Conference.

Forma Therapeutics Highlights Etavopivat Development Expansion and Introduces New Oncology Program from Research Pipeline at Inaugural Research and Development (R&D) Day

Retrieved on: 
Thursday, May 26, 2022
Oncology, FDA, Health, Clinical Trials, Pharmaceutical, Biotechnology, AR, Cancer, Program, DNA, R, ADP, Private Securities Litigation Reform Act, U.S. Securities and Exchange Commission, MDS, Annual report, Nasdaq, USP1, Vanderbilt University, SCD, Patient, Science, Goal, Sickle cell disease, File, Parpi, Phase, Health, Bone marrow, Therapy, Red blood cell, Erythropoiesis, Â, COVID-19, Form 10-Q, Investor, Trial of the century, PKR, Research, IND, Hemolytic anemia, Hematology, Prostate cancer, Thalassemia, Iron overload, Anemia, Safety, Transfusion-dependent anemia, Degenerative disease, LinkedIn, Mutation, RBC, SEC, Growth, CBP, Outline, Risk, Pharmaceutical industry, Vaccine, Medical device, Jet fuel, Forma

A live webcast will be available in the News & Investors section of Formas website.

Key Points: 
  • A live webcast will be available in the News & Investors section of Formas website.
  • We are also capitalizing on our knowledge of the emerging science of red blood cell health by exploring areas beyond hematologic disease.
  • Ongoing pre-clinical research is targeting areas of expansion for RBC health, novel mechanisms that may be complementary to etavopivat in rare hematology, and targeted oncology.
  • Forma Therapeutics is a clinical-stage biopharmaceutical company focused on the research, development and commercialization of novel therapeutics to transform the lives of patients with rare hematologic diseases and cancers.

Forma Named Best Innovative or Emerging Tech Solution at the 2022 HR Tech Awards

Retrieved on: 
Wednesday, May 18, 2022
Work, Dropbox, HR, AngelPad, Health, Stripe, Privacy, HRIS, Twic State, Research, Workforce, SAN, Lululemon Athletica, Industry, Freedom, RSVP, Caesars Entertainment (2020), GLOBE, Lighthouse, Emerging Capital Partners, Health insurance, Forma, Block

"Our platform puts the best interests of both employees and employers at the forefront -- it meets employees where they are and gives them unmatched choice and flexibility, while employers can quickly make adjustments to adapt to both employee and business needs," said Jason Fan, Forma's co-founder and chief executive officer. "This award is a huge honor and validates our team's hard work in easing the pain points associated with a traditional top-down approach to employer-sponsored benefits, and it motivates us to continue innovating at a high level."

Key Points: 
  • SAN FRANCISCO, May 18, 2022 (GLOBE NEWSWIRE) -- Forma , the life benefits platform, today announced that it was named a winner of a 2022 HR Tech Award for Best Innovative or Emerging Tech Solution in the Total Rewards and Employee Wellbeing category.
  • This year's HR Tech Awards recognize approximately 1% of the more than 5,000 providers that exist across HR technology, honoring them for their focus on creating solutions that solve problems their customers care about.
  • Forma is the life benefits platform that makes it easy to design and scale flexible benefits programs, whether your workforce is onsite, remote, or global.
  • This year's HR Tech Awards ceremony will be broadcast live on Wednesday, May 18 at 12 p.m. ET/9 a.m. PT in a special edition of Lighthouse Research & Advisory's "HR Tech Talks" live stream show.